Table 2.
Components of the original TSE framework.
| TSE component | Description | |
|---|---|---|
| Health impact | To what extent does the vaccine presentation protect against disease? Indicator: efficacy; effectiveness; factors affecting potency and timeliness of vaccination; duration of protection |
|
| Impact | Coverage | How does the vaccine presentation affect the proportion of the target population receiving the full vaccination schedule? Could the vaccine presentation decrease equity gaps in immunisation? Indicator: incremental coverage improvement (indicated by: vaccination schedule, storage requirements, administration requirements, acceptability, doses per container) |
| Safety | Does the vaccine presentation have a lower safety risk? Indicator: adverse events following immunisation (AEFI); risk of programmatic error (incorrect preparation, contamination, incorrect delivery, needle-stick injury) |
|
| Cost | Commodity cost | What is the cost of the vaccine and supplies, for complete vaccination factoring in wastage? Indicator: vaccine cost, delivery technology cost, safety box cost |
| Vaccine delivery cost | What are the operational costs to deliver the vaccine? Indicator: storage cost, transport cost, administration cost, waste disposal cost, monitoring and evaluation, introduction cost (including training, storage expansion, social mobilisation/communication) |
|